Evidence map›Paper›PMID 31466534›Full record

ArticleEpidemiology and infection2019

Seroprevalence of HPV serotypes 6, 11, 16 and 18 in unvaccinated children from Mexico City.

Reyna Lizette Pacheco-Domínguez, Ramón A Durazo-Arvizu, Angélica López-Hernández, Jesica Figueroa-Padilla, Julia Berenice Ramírez-González, Malaquías López-Cervantes

Open access · hybridAbstract read
In one paragraph

Article in Epidemiology and infection, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Is It Time to Reassess the Target Age of Human Papillomavirus Vaccination Globally?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Reyna Lizette Pacheco-DomínguezThe National Autonomous University of Mexico, Faculty of Medicine, Research Center on Population and Health Policies, Mexico City, Mexico.
Ramón A Durazo-ArvizuDepartment of Public Health, Loyola University Stritch School of Medicine, Mexico City, Mexico.
Angélica López-HernándezThe National Autonomous University of Mexico, Faculty of Medicine, Research Center on Population and Health Policies, Mexico City, Mexico.
Jesica Figueroa-PadillaThe National Autonomous University of Mexico, Faculty of Medicine, Research Center on Population and Health Policies, Mexico City, Mexico.
Julia Berenice Ramírez-GonzálezThe National Autonomous University of Mexico, Faculty of Medicine, Research Center on Population and Health Policies, Mexico City, Mexico.
Malaquías López-CervantesThe National Autonomous University of Mexico, Faculty of Medicine, Research Center on Population and Health Policies, Mexico City, Mexico.ORCID 0000-0001-9936-8427
Universidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data regarding humoral immunity against HPV infection are scarce. Most analyses focus on the identification of viruses on mucous membranes and primarily refer to women of reproductive age. The aim of this work was to estimate the seroprevalence of antibodies against HPV serotypes 6, 11, 16 and 18 among unvaccinated boys living in Mexico City. A cross-sectional study of 257 male students from 48 public primary schools in Mexico City, whose ages fluctuated between 9 and 14 years, was carried out. Immunological status was assessed by applying the competitive Luminex Immunoassay of HPV (cLIA). Among the study population, we initially found that 38.52% (n = 99) of the children tested positive against one or more of the HPV 6, 11, 16 and/or 18 serotypes. The most commonly found serotype was isolated HPV 18 or in combination with other serotypes (22% and 31%, respectively), followed by HPV 6 with frequencies of 4.7% and 11%, respectively; however, lower frequencies were estimated for HPV 16 (2%; 6%) and isolated HPV 11, 4%. If a second set of cut-off points for seropositivity is applied, the overall prevalence for any serotype is reduced to 15.2%. As it appears that a significant sector of the study population has had basal contact with an HPV serotype, we recommend considering the possibility of vaccination against HPV at earlier ages.

Indexed as

SerogroupAdolescentAntibodies, ViralChildCitiesCross-Sectional StudiesHumansMaleMexicoPapillomaviridaePapillomavirus InfectionsSchoolsSeroepidemiologic StudiesAntibodies, ViralChildrenHPVMexicopreadolescents

Identifiers

PMID31466534
PMCPMC6805765
OpenAlexW2970717557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.